Duopharma Biotech Bhd. stock analysis
Duopharma Biotech Bhd. (7148) Stock Price & Analysis
7148 Stock Chart & Stats
- Day’s Range
- MYR 1.07 - MYR 1.13
- 52-Week Range
- MYR 1.06 - MYR 1.57
- Previous Close
- MYR 1.11
- Volume
- N/A
- Average Volume (3M)
- 273.68K
- Market Cap
- MYR 1.03B
- Enterprise Value
- MYR 1.36B
- Total Cash (Recent Filing)
- MYR 255.99M
- Total Debt (Recent Filing)
- MYR 471.60M
- Price to Earnings (P/E)
- 10.1
- Beta
- 0.58
- Next Earnings
- Nov 11, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 03, 2026
- Dividend Yield
- 4.25%
7148 FAQ
What was Duopharma Biotech Bhd.’s price range in the past 12 months?
What is Duopharma Biotech Bhd.’s market cap?
When is Duopharma Biotech Bhd.’s upcoming earnings report date?
How were Duopharma Biotech Bhd.’s earnings last quarter?
Is Duopharma Biotech Bhd. overvalued?
Does Duopharma Biotech Bhd. pay dividends?
What is Duopharma Biotech Bhd.’s EPS estimate?
How many shares outstanding does Duopharma Biotech Bhd. have?
What happened to Duopharma Biotech Bhd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Duopharma Biotech Bhd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Duopharma Biotech Bhd.
Duopharma Biotech Berhad, an investment holding firm, is actively engaged in the pharmaceutical sector. Its operations encompass the research, development, manufacturing, distribution, and import of medicinal products, serving markets in Malaysia and internationally. The company's extensive product range includes consumer health items like vitamins, nutritional supplements, pain relievers, eye care solutions, antacids, and skincare products. It also provides generic medications across various therapeutic classes, such as cardiovascular, dermatological, hormonal, respiratory, neurological, musculoskeletal, and anti-infective agents. Furthermore, Duopharma offers specialized pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables, addressing ailments like diabetes, cancer, cardiovascular diseases, and renal disorders. Notable products include vascor, insugen, kytron, and unihepa. Its well-known brands feature Champs, Flavettes, Eye Glo, Proviton, Naturalle, and Uphamol. Beyond its core pharmaceutical activities, the company is also involved in property management and the trading of chemical products. Founded in 1978 and headquartered in Kuala Lumpur, Malaysia, the company adopted its current name, Duopharma Biotech Berhad, in February 2019, having previously been known as CCM Duopharma Biotech Berhad.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wan Amir-Jeffery Bin Wan Abdul Majid
- Employees
- 2,001
- Website
- duopharmabiotech.com
- Address
- CIMB HUB, Kuala Lumpur, SE, 50250, MY
Duopharma Biotech Bhd. (7148) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 6 | 15 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 0 | 0 | 12 |

